Most students satisfied with Oriel preregistration training offers, study finds
Almost three-quarters (72.9%) of survey respondents were “satisfied or highly satisfied” with the preregistration training programme offers they received through Oriel, according to a study of student experience of the recruitment scheme.
The authors of the study, published in BMC Medical Reports, said the online survey was circulated to around 2800 pharmacy students in England and Wales, who were asked about the preregistration offers they received in 2017/2018, the year the survey was introduced. The researchers received 327 completed surveys in response.
A high proportion (84.1%) of respondents said they received an offer in the first round of recruitment, although a gender difference was observed: 88% of female applications received an offer in the first round, compared with 76% of male applicants.
All pharmacy hospital preregistration placements are advertised through Oriel, as are some, but not all, community pharmacy placements.
Around half (49.2%) of respondents were “satisfied or highly satisfied” with Oriel’s preferencing process, through which applicants select their preferred options for preregistration training programmes. But the study authors noted that while most (73.6%) applicants felt they had enough time for the preferencing process, just under a fifth (18.1%) said the timeframe was “inadequate”. In 2017, the preferencing window ran from 31 July to 21 August.
The British Pharmaceutical Students’ Association (BPSA) has conducted a survey of students’ experience of Oriel for the 2018/2019 intake. Although the results of this survey have yet to be published, a spokesperson for the BPSA said that around 40% of respondents reported that their experience of the preferencing system was either “good or very good”.
In 2017 a BPSA survey found that just over half (53.2%) of pharmacy students rated the overall experience of Oriel as “poor” or “very poor”.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207453
Recommended from Pharmaceutical Press